Lentinan alleviates diabetic cardiomyopathy by suppressing CAV1/SDHA-regulated mitochondrial dysfunction
2023 · Biomedicine & Pharmacotherapy · 19 citations
https://doi.org/10.1016/j.biopha.2023.115645
J
Jinlan Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
519
Citations
12
h-index
13
i10-index
Jinlan Luo is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Eicosanoids and Hypertension Pharmacology & Diet, Metabolism, and Disease & Diabetes Treatment and Management. The author has an h-index of 12, co-authored 32 publications.
ORCID: 0000-0002-2695-246XPapers by this author
worksCardiac-specific PFKFB3 overexpression prevents diabetic cardiomyopathy via enhancing OPA1 stabilization mediated by K6-linked ubiquitination
2024 · Cellular and Molecular Life Sciences · 15 citations
https://doi.org/10.1007/s00018-024-05257-5
Erythrabyssin ll is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer
2025 · iScience · 1 citations
https://doi.org/10.1016/j.isci.2025.112801
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat